Biognosys: Biognosys to commercialise Alamar Biosciences' NULISA proteomics assay range
The selection of assays will allow the identification of cytokines, chemokines and neurodegenerative markers in a small plasma sample
Read full article »
Biognosys is a Switzerland-based SaaS platform that offers mass spectrometry-powered proteomics solutions for cell line engineering and protein quantification applications.
Read more